RNase H Activity: Structure, Specificity, and Function in Reverse Transcription

Overview

Journal Virus Res

Specialty Microbiology

Date 2008 Feb 12

PMID 18261820

Citations 69

Authors

Sharon J Schultz

James J Champoux

Affiliations

Soon will be listed here.

Abstract

This review compares the well-studied RNase H activities of human immunodeficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (MoMLV) reverse transcriptases. The RNase H domains of HIV-1 and MoMLV are structurally very similar, with functions assigned to conserved subregions like the RNase H primer grip and the connection subdomain, as well as to distinct features like the C-helix and loop in MoMLV RNase H. Like cellular RNases H, catalysis by the retroviral enzymes appears to involve a two-metal ion mechanism. Unlike cellular RNases H, the retroviral RNases H display three different modes of cleavage: internal, DNA 3' end-directed, and RNA 5' end-directed. All three modes of cleavage appear to have roles in reverse transcription. Nucleotide sequence is an important determinant of cleavage specificity with both enzymes exhibiting a preference for specific nucleotides at discrete positions flanking an internal cleavage site as well as during tRNA primer removal and plus-strand primer generation. RNA 5' end-directed and DNA 3' end-directed cleavages show similar sequence preferences at the positions closest to a cleavage site. A model for how RNase H selects cleavage sites is presented that incorporates both sequence preferences and the concept of a defined window for allowable cleavage from a recessed end. Finally, the RNase H activity of HIV-1 is considered as a target for anti-virals as well as a participant in drug resistance.

Citing Articles

Technologies for Targeted RNA Degradation and Induced RNA Decay.

Mikutis S, Bernardes G Chem Rev. 2024; 124(23):13301-13330.

PMID: 39499674 PMC: 11638902. DOI: 10.1021/acs.chemrev.4c00472.

An ultrasensitive label-free RNase H assay based on transcription of fluorogenic light-up aptamer.

Lee J, Kim H, Li Y, Lee S, Park H Nanoscale Adv. 2024; 6(7):1926-1931.

PMID: 38545293 PMC: 10964761. DOI: 10.1039/d3na00975k.

Improved protocol for polymerase and reverse transcriptase production and application to a point-of-care diagnostics system.

de Souza L, Silva I, Celis-Silva G, Raddatz B, Imamura L, Kim E Exp Biol Med (Maywood). 2023; 248(19):1671-1683.

PMID: 38088106 PMC: 10723028. DOI: 10.1177/15353702231215815.

A Practical Approach to Bicyclic Carbamoyl Pyridones with Application to the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors.

Mahajan P, Smith S, Hughes S, Zhao X, Burke Jr T Molecules. 2023; 28(3).

PMID: 36771093 PMC: 9919513. DOI: 10.3390/molecules28031428.

Progression of Antiviral Agents Targeting Viral Polymerases.

Peng S, Wang H, Wang Z, Wang Q Molecules. 2022; 27(21).

PMID: 36364196 PMC: 9654062. DOI: 10.3390/molecules27217370.

References

Kanaya S, Ikehara M . Importance of the positive charge cluster in Escherichia coli ribonuclease HI for the effective binding of the substrate. J Biol Chem. 1991; 266(18):11621-7. View

Huber H, Richardson C . Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase. J Biol Chem. 1990; 265(18):10565-73. View

Schultz S, Whiting S, Champoux J . Cleavage specificities of Moloney murine leukemia virus RNase H implicated in the second strand transfer during reverse transcription. J Biol Chem. 1995; 270(41):24135-45. DOI: 10.1074/jbc.270.41.24135. View

Jones J, Taylor B, Wilkin T, Hammer S . Advances in antiretroviral therapy. Top HIV Med. 2007; 15(2):48-82. View

Roda R, Balakrishnan M, Hanson M, Wohrl B, Le Grice S, Roques B . Role of the Reverse Transcriptase, Nucleocapsid Protein, and Template Structure in the Two-step Transfer Mechanism in Retroviral Recombination. J Biol Chem. 2003; 278(34):31536-46. DOI: 10.1074/jbc.M304608200. View

Zhang W, Svarovskaia E, Barr R, Pathak V . Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc Natl Acad Sci U S A. 2002; 99(15):10090-5. PMC: 126629. DOI: 10.1073/pnas.152186199. View

Domaoal R, Demeter L . Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors. Int J Biochem Cell Biol. 2004; 36(9):1735-51. DOI: 10.1016/j.biocel.2004.02.026. View

Wohrl B, Moelling K . Coupling of reverse transcriptase and RNase H during HIV-1 replication. Behring Inst Mitt. 1991; (89):100-7. View

Kopka M, Lavelle L, Han G, Ng H, Dickerson R . An unusual sugar conformation in the structure of an RNA/DNA decamer of the polypurine tract may affect recognition by RNase H. J Mol Biol. 2003; 334(4):653-65. DOI: 10.1016/j.jmb.2003.09.057. View

10.

McWilliams M, Julias J, Sarafianos S, Alvord W, Arnold E, Hughes S . Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology. 2006; 348(2):378-88. DOI: 10.1016/j.virol.2005.12.042. View

11.

Mandal D, Dash C, Le Grice S, Prasad V . Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function. Nucleic Acids Res. 2006; 34(10):2853-63. PMC: 1474072. DOI: 10.1093/nar/gkl360. View

12.

Archer R, Wisniewski M, Bambara R, Demeter L . The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages. Biochemistry. 2001; 40(13):4087-95. DOI: 10.1021/bi002328a. View

13.

Goedken E, Marqusee S . Co-crystal of Escherichia coli RNase HI with Mn2+ ions reveals two divalent metals bound in the active site. J Biol Chem. 2000; 276(10):7266-71. DOI: 10.1074/jbc.M009626200. View

14.

Kvaratskhelia M, Budihas S, Le Grice S . Pre-existing distortions in nucleic acid structure aid polypurine tract selection by HIV-1 reverse transcriptase. J Biol Chem. 2002; 277(19):16689-96. DOI: 10.1074/jbc.M109914200. View

15.

Lim D, Gregorio G, Bingman C, Martinez-Hackert E, Hendrickson W, Goff S . Crystal structure of the moloney murine leukemia virus RNase H domain. J Virol. 2006; 80(17):8379-89. PMC: 1563865. DOI: 10.1128/JVI.00750-06. View

16.

Julias J, McWilliams M, Sarafianos S, Alvord W, Arnold E, Hughes S . Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage. J Virol. 2004; 78(23):13315-24. PMC: 524982. DOI: 10.1128/JVI.78.23.13315-13324.2004. View

17.

Gao G, Orlova M, Georgiadis M, Hendrickson W, Goff S . Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc Natl Acad Sci U S A. 1997; 94(2):407-11. PMC: 19524. DOI: 10.1073/pnas.94.2.407. View

18.

Miles L, Agresta B, Khan M, Tang S, Levin J, Powell M . Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity. J Virol. 2005; 79(11):6859-67. PMC: 1112125. DOI: 10.1128/JVI.79.11.6859-6867.2005. View

19.

Nowotny M, Yang W . Stepwise analyses of metal ions in RNase H catalysis from substrate destabilization to product release. EMBO J. 2006; 25(9):1924-33. PMC: 1456928. DOI: 10.1038/sj.emboj.7601076. View

20.

Jones F, Hughes S . In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology. 2006; 360(2):341-9. DOI: 10.1016/j.virol.2006.10.008. View